Nitric oxide and the non-adrenergic non-cholinergic neurotransmission.
In the early 1960s, the first evidence was reported demonstrating neurally mediated responses in the presence of adrenergic and cholinergic antagonists, leading to the introduction of the concept of non-adrenergic non-cholinergic neurotransmission. The inhibitory component of this part of the autonomic nervous system has been illustrated in numerous organ systems mediating a wide range of physiological events. Since the discovery of these nerves, several substances have been proposed as putative neurotransmitter, with ATP and vasoactive intestinal polypeptide as main candidates. Finally, the ongoing research on the nature of the substance released by these nerves has generated the nitrergic theory proposing nitric oxide as putative neurotransmitter. By now, increasing evidence is reported to support the idea that inhibitory neurons release more neurotransmitters, interacting with each other at pre- and/or postsynaptic levels.
Boeckxstaens
G E
GE
Division of Gastroenterology, Academic Medical Center, Amsterdam, The Netherlands.
Pelckmans
P A
PA
D000818:Animals; D001341:Autonomic Nervous System / Q000502:physiology*; D006801:Humans; D018377:Neurotransmitter Agents / Q000502:physiology*; D009569:Nitric Oxide / Q000502:physiology*; D009435:Synaptic Transmission / Q000502:physiology*
D018377:Neurotransmitter Agents; D009569:Nitric Oxide